XTX Topco Ltd Has $1.34 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

XTX Topco Ltd raised its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 398.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,422 shares of the medical technology company's stock after purchasing an additional 4,335 shares during the period. XTX Topco Ltd's holdings in Teleflex were worth $1,341,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. iSAM Funds UK Ltd acquired a new position in shares of Teleflex during the 3rd quarter worth $397,000. Wahed Invest LLC grew its position in Teleflex by 15.8% in the third quarter. Wahed Invest LLC now owns 1,142 shares of the medical technology company's stock valued at $282,000 after acquiring an additional 156 shares during the last quarter. State Street Corp raised its stake in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock worth $508,757,000 after acquiring an additional 21,291 shares in the last quarter. Quarry LP lifted its holdings in shares of Teleflex by 71.5% in the third quarter. Quarry LP now owns 391 shares of the medical technology company's stock worth $97,000 after acquiring an additional 163 shares during the last quarter. Finally, Royal London Asset Management Ltd. boosted its stake in shares of Teleflex by 3.0% in the 3rd quarter. Royal London Asset Management Ltd. now owns 19,364 shares of the medical technology company's stock valued at $4,789,000 after purchasing an additional 555 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Up 1.3 %

Shares of NYSE TFX traded up $2.43 during trading on Monday, reaching $187.08. The company had a trading volume of 397,328 shares, compared to its average volume of 383,727. The stock has a market cap of $8.69 billion, a P/E ratio of 37.19, a PEG ratio of 1.89 and a beta of 1.16. The company's fifty day moving average price is $212.96 and its 200-day moving average price is $221.34. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $184.19 and a 12 month high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million for the quarter, compared to analysts' expectations of $768.68 million. During the same period in the prior year, the business posted $3.64 earnings per share. The firm's revenue was up 2.4% on a year-over-year basis. As a group, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's dividend payout ratio is presently 27.04%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on TFX shares. Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Mizuho dropped their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Truist Financial reaffirmed a "hold" rating and issued a $227.00 target price (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Finally, StockNews.com raised Teleflex from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $259.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.